Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Glucotrack (GCTK) Operating Expenses (2016 - 2020)

Glucotrack's Operating Expenses history spans 7 years, with the latest figure at $878000.0 for Q4 2020.

  • For the quarter ending Q4 2020, Operating Expenses rose 30.28% year-over-year to $878000.0, compared with a TTM value of $3.1 million through Dec 2020, down 15.67%, and an annual FY2025 reading of $16.1 million, up 10.61% over the prior year.
  • Operating Expenses for Q4 2020 was $878000.0 at Glucotrack, down from $887000.0 in the prior quarter.
  • The five-year high for Operating Expenses was $3.1 million in Q4 2017, with the low at $611000.0 in Q2 2020.
  • Average Operating Expenses over 5 years is $1.5 million, with a median of $1.4 million recorded in 2016.
  • Year-over-year, Operating Expenses soared 116.61% in 2017 and then crashed 67.83% in 2018.
  • Tracing GCTK's Operating Expenses over 5 years: stood at $1.5 million in 2016, then soared by 116.61% to $3.1 million in 2017, then crashed by 67.83% to $1.0 million in 2018, then crashed by 33.36% to $673913.0 in 2019, then surged by 30.28% to $878000.0 in 2020.
  • Per Business Quant, the three most recent readings for GCTK's Operating Expenses are $878000.0 (Q4 2020), $887000.0 (Q3 2020), and $611000.0 (Q2 2020).